ilmscore | Will I Apply? | CA Rachana Ranade

Will I Apply? | CA Rachana Ranade

Published: 2023-04-26
Status: Available | Analyzed

Predictions from this Video

Total: 7
Correct: 0
Incorrect: 0
Pending: 7
Unrated: 0
Prediction
Topic
Status
The increasing median age in India and a more sedentary lifestyle with poor diet are predicted to lead to more diseases, benefiting pharmaceutical companies by increasing product sales.
"in in the year 2036 the the average median age will be around 35 years so whatever median age we are at right now 28 years this will move up to 35 years plus we are into more of a sedentary lifestyle these days a lot of stress poor diet you know not a very healthy lifestyle per se and all these are going to lead to certain diseases and that is why this company is going to be I should not be saying that but this company is going to be happy if you're going to fall ill because that is a that is when they are they'll be able to sell more of their products"
Indian Pharmaceutical Market Growth
Pending
India's healthcare spending as a proportion of GDP (2.1%) is among the lowest compared to BRICS nations, indicating significant potential for future sales growth in the sector.
"if I'm talking about how much percentage we are spending as a proportion of GDP approximately we are spending just 2.1 percent of the overall GDP that is pretty less why I'm saying pretty less this is amongst the lowest even when I'm comparing it with Nations like brics Brazil Russia China South Africa right eyes India so if we are the lowest among the brics countries as well again there's a big scope for you know there's a big room left for increase of sales"
Indian Healthcare Spending
Pending
Following its listing, Mankind Pharma is expected to offload an additional 1.5% of shares within the next three years to comply with SEBI regulations (reducing holding below 75%), which will lead to an increase in share supply in the market.
"post issue the percentages have I written it somewhere maybe towards the end holding is the overall holding is 76.5 so now what happens as per the rule of semi uh their holding should be below 75 percent within three years so right now they are diluting a grade it is going to be an ofs but in spite of this company getting listed there's another one and a half percentage which is yet to be offloaded and that will be offloaded in the coming three years so again you have to remember this there is going to be another supply of shares in the market"
Mankind Pharma Share Supply
Pending
The IPO of Mankind Pharma is predicted to have a listing gain of approximately 8-10%, which is considered optimistic and not indicative of a massive surge.
"based on the GMT today which is six percent based on subscription that I can see right now I see somewhere around upper side upper side eight to ten percent of listing that also is on a little bit optimistic side to be honest"
Mankind Pharma IPO Listing
Pending
The increasing median age in India (projected to reach 35 by 2036) combined with sedentary lifestyles, stress, and poor diet will likely lead to an increase in diseases, benefiting pharmaceutical companies like Mankind Pharma by driving sales.
"in in the year 2036 the the average median age will be around 35 years so whatever median age we are at right now 28 years this will move up to 35 years plus we are into more of a sedentary lifestyle these days a lot of stress poor diet you know not a very healthy lifestyle per se and all these are going to lead to certain diseases and that is why this company is going to be I should not be saying that but this company is going to be happy if you're going to fall ill because that is a that is when they are they'll be able to sell more of their products"
Pharmaceutical Industry Growth
Pending
Mankind Pharma's post-IPO shareholding will require a further 1.5% dilution within three years to comply with SEBI regulations, potentially leading to a slight correction in share prices due to increased supply.
"post issue the percentages have I written it somewhere maybe towards the end holding is the overall holding is 76.5 so now what happens as per the rule of semi uh their holding should be below 75 percent within three years so right now they are diluting a grade it is going to be an ofs but in spite of this company getting listed there's another one and a half percentage which is yet to be offloaded and that will be offloaded in the coming three years so again you have to remember this there is going to be another supply of shares in the market and when there is going to be more Supply at that point in time there is a possibility that the share prices May correct a little bit"
Mankind Pharma Stock Supply
Pending
The speaker predicts listing gains for Mankind Pharma to be around 8-10% at the upper end, considering the current grey market premium (GMP) of 6% and subscription levels.
"based on the GMT today which is six percent based on subscription that I can see right now I see somewhere around upper side upper side eight to ten percent of listing that also is on a little bit optimistic side to be honest"
Mankind Pharma Listing Gains
Pending